Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis

NCT02054572 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis

Interventions

DRUG: [¹⁴C]Etelcalcetide

Sponsor

Amgen